EMAIL THIS PAGE TO A FRIEND

Peptides

Design and evaluation of novel natriuretic peptide derivatives with improved pharmacokinetic and pharmacodynamic properties.


PMID 28899838

Abstract

C-type natriuretic peptide (CNP) and its receptor, natriuretic peptide receptor B (NPR-B), are potent positive regulators of endochondral bone growth, making the CNP pathway one of the most promising therapeutic targets for the treatment of growth failure. However, the administration of exogenous CNP is not fully effective, due to its rapid clearance in vivo. Modification of CNP to potentially druggable derivatives may result in increased resistance to proteolytic degradation, longer plasma half-life (T

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

T6031
DL-Thiorphan, ≥98% (TLC)
C12H15NO3S